Condition

Stage II Renal Cell Cancer AJCC v7 (3)

Stage III Renal Cell Cancer AJCC v7 (3)

Clear Cell Renal Cell Carcinoma (2)

Metastatic Renal Cell Carcinoma (2)

Stage I Renal Cell Cancer AJCC v6 and v7 (2)

Sarcomatoid Renal Cell Carcinoma (1)

Stage IV Renal Cell Cancer AJCC v7 (1)

Unclassified Renal Cell Carcinoma (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Terminated (1)

Phase

phase 3 (2)

phase 1 (1)

Sponsor

National Cancer Institute (NCI) (3)

Collaborator

Canadian Cancer Trials Group (1)

Cancer and Leukemia Group B (1)

NCIC Clinical Trials Group (1)

Southwest Oncology Group (1)

Study Documents

Intervention Type

biological (2)

other (2)

procedure (2)

drug (1)

Funder Type

NIH (3)

Study Type

Interventional (3)

stage ii renal cell cancer ajcc v7

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Metastatic Renal Cell Carcinoma, Sarcomatoid Renal Cell Carcinoma, Stage II Renal Cell Cancer AJCC v7 Trial in Canada, Israel,

Active, not recruiting

Metastatic Renal Cell Carcinoma
+4 more

Nephrectomy
+4 more

Birmingham, Alabama
+414 more

Dec 30, 2022

Clear Cell Renal Cell Carcinoma, Stage I Renal Cell Cancer AJCC v6 and v7, Stage II Renal Cell Cancer AJCC v7 Trial in Canada,

Completed

Has Results

Clear Cell Renal Cell Carcinoma
+3 more

Laboratory Biomarker Analysis
+4 more

Birmingham, Alabama
+986 more

Jan 13, 2022

Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Stage I Renal Cell Cancer AJCC v6 and v7 Trial in New York

Terminated

Clear Cell Renal Cell Carcinoma
+5 more

Metastasectomy
+2 more

New York, New York

Memorial Sloan Kettering Cancer Center

Oct 22, 2020